<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Br J Pharmacol</journal-id>
<journal-id journal-id-type="iso-abbrev">Br. J. Pharmacol</journal-id>
<journal-id journal-id-type="doi">10.1111/(ISSN)1476-5381</journal-id>
<journal-id journal-id-type="publisher-id">BPH</journal-id>
<journal-title-group>
<journal-title>British Journal of Pharmacology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0007-1188</issn>
<issn pub-type="epub">1476-5381</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28217866</article-id>
<article-id pub-id-type="pmc">5466539</article-id>
<article-id pub-id-type="doi">10.1111/bph.13754</article-id>
<article-id pub-id-type="publisher-id">BPH13754</article-id>
<article-id pub-id-type="other">2016-BJP-1214-R.R1</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Review Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Review Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Zebrafish models in neuropsychopharmacology and CNS drug discovery</article-title>
<alt-title alt-title-type="right-running-head">Zebrafish models in neuropsychopharmacology</alt-title>
<alt-title alt-title-type="left-running-head">K M Khan et al.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="bph13754-cr-0001">
<name>
<surname>Khan</surname>
<given-names>Kanza M</given-names>
</name>
<xref ref-type="aff" rid="bph13754-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="bph13754-cr-0002">
<name>
<surname>Collier</surname>
<given-names>Adam D</given-names>
</name>
<xref ref-type="aff" rid="bph13754-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="bph13754-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="bph13754-cr-0003">
<name>
<surname>Meshalkina</surname>
<given-names>Darya A</given-names>
</name>
<xref ref-type="aff" rid="bph13754-aff-0002">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="bph13754-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="bph13754-cr-0004">
<name>
<surname>Kysil</surname>
<given-names>Elana V</given-names>
</name>
<xref ref-type="aff" rid="bph13754-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="bph13754-cr-0005">
<name>
<surname>Khatsko</surname>
<given-names>Sergey L</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5921-6680</contrib-id>
<xref ref-type="aff" rid="bph13754-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="bph13754-cr-0006">
<name>
<surname>Kolesnikova</surname>
<given-names>Tatyana</given-names>
</name>
<xref ref-type="aff" rid="bph13754-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="bph13754-cr-0007">
<name>
<surname>Morzherin</surname>
<given-names>Yury Yu</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1333-6676</contrib-id>
<xref ref-type="aff" rid="bph13754-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="bph13754-cr-0008">
<name>
<surname>Warnick</surname>
<given-names>Jason E</given-names>
</name>
<xref ref-type="aff" rid="bph13754-aff-0002">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="bph13754-aff-0005">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="bph13754-cr-0009">
<name>
<surname>Kalueff</surname>
<given-names>Allan V</given-names>
</name>
<address>
<email>avkalueff@gmail.com</email>
</address>
<xref ref-type="aff" rid="bph13754-aff-0002">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="bph13754-aff-0003">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="bph13754-aff-0004">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="bph13754-aff-0006">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="bph13754-cr-0010">
<name>
<surname>Echevarria</surname>
<given-names>David J</given-names>
</name>
<address>
<email>David.echevarria@usm.edu</email>
</address>
<xref ref-type="aff" rid="bph13754-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="bph13754-aff-0002">
<sup>2</sup>
</xref>
</contrib>
</contrib-group>
<aff id="bph13754-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Psychology</named-content>
<institution>University of Southern Mississippi</institution>
<named-content content-type="city">Hattiesburg</named-content>
<named-content content-type="country-part">MS</named-content>
<country country="US">USA</country>
</aff>
<aff content-type="private-address" id="bph13754-aff-0002">
<label>
<sup>2</sup>
</label>
<institution>The International Zebrafish Neuroscience Research Consortium (ZNRC)</institution>
<named-content content-type="city">Slidell</named-content>
<named-content content-type="country-part">LA</named-content>
<country country="US">USA</country>
</aff>
<aff id="bph13754-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Institute of Translational Biomedicine</named-content>
<institution>St. Petersburg State University</institution>
<named-content content-type="city">St. Petersburg</named-content>
<country country="RU">Russia</country>
</aff>
<aff content-type="private-address" id="bph13754-aff-0004">
<label>
<sup>4</sup>
</label>
<institution>Ural Federal University</institution>
<named-content content-type="city">Ekaterinburg</named-content>
<country country="RU">Russia</country>
</aff>
<aff id="bph13754-aff-0005">
<label>
<sup>5</sup>
</label>
<named-content content-type="organisation-division">Department of Behavioral Sciences</named-content>
<institution>Arkansas Tech University</institution>
<named-content content-type="city">Russellville</named-content>
<named-content content-type="country-part">AR</named-content>
<country country="US">USA</country>
</aff>
<aff id="bph13754-aff-0006">
<label>
<sup>6</sup>
</label>
<named-content content-type="organisation-division">Research Institute of Marine Drugs and Nutrition, College of Food Science and Technology</named-content>
<institution>Guangdong Ocean University</institution>
<named-content content-type="city">Zhanjiang</named-content>
<named-content content-type="country-part">Guangdong</named-content>
<country country="CN">China</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold> Dr Allan V. Kalueff, Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, Russia, and David J. Echevarria, Department of Psychology, University of Southern Mississippi, Hattiesburg, MS, USA. E‐mail: <email>avkalueff@gmail.com</email>; <email>David.echevarria@usm.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>05</day>
<month>4</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>7</month>
<year>2017</year>
</pub-date>
<volume>174</volume>
<issue>13</issue>
<issue-id pub-id-type="doi">10.1111/bph.v174.13</issue-id>
<fpage>1925</fpage>
<lpage>1944</lpage>
<history>
<date date-type="received">
<day>03</day>
<month>1</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>11</day>
<month>2</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>14</day>
<month>2</month>
<year>2017</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2017 The British Pharmacological Society <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2017 The British Pharmacological Society</copyright-statement>
</permissions>
<self-uri content-type="pdf" xlink:href="file:BPH-174-1925.pdf" xlink:type="simple"></self-uri>
<abstract>
<p>Despite the high prevalence of neuropsychiatric disorders, their aetiology and molecular mechanisms remain poorly understood. The zebrafish (<styled-content style="fixed-case"><styled-content style="italic-in-any-context">Danio rerio</styled-content></styled-content>) is increasingly utilized as a powerful animal model in neuropharmacology research and <italic>in vivo</italic> drug screening. Collectively, this makes zebrafish a useful tool for drug discovery and the identification of disordered molecular pathways. Here, we discuss zebrafish models of selected human neuropsychiatric disorders and drug‐induced phenotypes. As well as covering a broad range of brain disorders (from anxiety and psychoses to neurodegeneration), we also summarize recent developments in zebrafish genetics and small molecule screening, which markedly enhance the disease modelling and the discovery of novel drug targets.</p>
</abstract>
<funding-group>
<award-group>
<funding-source>Russian Foundation for Basic Research</funding-source>
<award-id>16‐04‐00851</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="2"></fig-count>
<table-count count="1"></table-count>
<page-count count="20"></page-count>
<word-count count="9040"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>bph13754</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>July 2017</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.1.1 mode:remove_FC converted:09.06.2017</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation id="bph13754-cit-0000" publication-type="journal">
<string-name>
<surname>Khan</surname>, <given-names>K. M.</given-names>
</string-name>, <string-name>
<surname>Collier</surname>, <given-names>A. D.</given-names>
</string-name>, <string-name>
<surname>Meshalkina</surname>, <given-names>D. A.</given-names>
</string-name>, <string-name>
<surname>Kysil</surname>, <given-names>E. V.</given-names>
</string-name>, <string-name>
<surname>Khatsko</surname>, <given-names>S. L.</given-names>
</string-name>, <string-name>
<surname>Kolesnikova</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Morzherin</surname>, <given-names>Y. Y.</given-names>
</string-name>, <string-name>
<surname>Warnick</surname>, <given-names>J. E.</given-names>
</string-name>, <string-name>
<surname>Kalueff</surname>, <given-names>A. V.</given-names>
</string-name>, and <string-name>
<surname>Echevarria</surname>, <given-names>D. J.</given-names>
</string-name> (<year>2017</year>) <article-title>Zebrafish models in neuropsychopharmacology and CNS drug discovery</article-title>. <source/>British Journal of Pharmacology, <volume>174</volume>: <fpage>1925</fpage>–<lpage>1944</lpage>. doi: <ext-link ext-link-type="doi" xlink:href="10.1111/bph.13754">10.1111/bph.13754</ext-link>.</mixed-citation>
</p>
</notes>
</front>
</article>
</pmc-articleset>